Literature DB >> 8016094

Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.

H L Hsu1, I Wadman, J T Tsan, R Baer.   

Abstract

Tumor-specific activation of the TAL1 gene is the most common genetic defect associated with T-cell acute lymphoblastic leukemia. The TAL1 gene products possess a basic helix-loop-helix (bHLH) motif, a protein-dimerization and DNA-binding domain found in several transcription factors. TAL1 polypeptides interact, in vitro and in vivo, with class A bHLH proteins (e.g., E47) to form heterodimers with sequence-specific DNA-binding activity. In this study, we show that TAL1 can regulate the transcription of an artificial reporter gene that contains binding sites for bHLH heterodimers involving TAL1. Transcription of the reporter is strongly induced by E47-E47 homodimers and moderately induced by TAL1-E47 heterodimers. Thus, in a cellular environment that allows formation of E47-E47 homodimers (e.g., in the absence of Id regulatory proteins) TAL1 can repress transcription by recruiting E47 into bHLH complexes with less transcriptional activity (i.e., TAL1-E47 heterodimers). However, in other settings TAL1 can activate transcription because TAL1-E47 heterodimers are more resistant to negative regulation by Id proteins. Hence, TAL1 can potentially regulate transcription in either a positive or negative fashion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8016094      PMCID: PMC44114          DOI: 10.1073/pnas.91.13.5947

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Transcription activation by the adenovirus E1a protein.

Authors:  J W Lillie; M R Green
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

2.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence.

Authors:  C Murre; P S McCaw; H Vaessin; M Caudy; L Y Jan; Y N Jan; C V Cabrera; J N Buskin; S D Hauschka; A B Lassar
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

3.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.

Authors:  C Murre; P S McCaw; D Baltimore
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

4.  lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif.

Authors:  J D Mellentin; S D Smith; M L Cleary
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

5.  A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing.

Authors:  K A Lee; A Bindereif; M R Green
Journal:  Gene Anal Tech       Date:  1988 Mar-Apr

6.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif.

Authors:  C G Begley; P D Aplan; S M Denning; B F Haynes; T A Waldmann; I R Kirsch
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme.

Authors:  S Andersson; D L Davis; H Dahlbäck; H Jörnvall; D W Russell
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

9.  Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells.

Authors:  H L Hsu; I Wadman; R Baer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

10.  Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma.

Authors:  L R Finger; J Kagan; G Christopher; J Kurtzberg; M S Hershfield; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

View more
  35 in total

1.  The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene.

Authors:  J Wang; S N Jani-Sait; E A Escalon; A J Carroll; P J de Jong; I R Kirsch; P D Aplan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

2.  Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development.

Authors:  Toni Portis; Richard Longnecker
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.

Authors:  Teresa Palomero; Duncan T Odom; Jennifer O'Neil; Adolfo A Ferrando; Adam Margolin; Donna S Neuberg; Stuart S Winter; Richard S Larson; Wei Li; X Shirley Liu; Richard A Young; A Thomas Look
Journal:  Blood       Date:  2006-04-18       Impact factor: 22.113

4.  Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.

Authors:  Thorsten M Schlaeger; Anna Schuh; Simon Flitter; Andreas Fisher; Hanna Mikkola; Stuart H Orkin; Paresh Vyas; Catherine Porcher
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

5.  Sequence determinants of DNA binding by the hematopoietic helix-loop-helix transcription factor TAL1: importance of sequences flanking the E-box core.

Authors:  K A Gould; E H Bresnick
Journal:  Gene Expr       Date:  1998

6.  Chromatin immunoselection defines a TAL-1 target gene.

Authors:  S Cohen-Kaminsky; L Maouche-Chrétien; L Vitelli; M A Vinit; I Blanchard; M Yamamoto; C Peschle; P H Roméo
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

7.  Determinants of protein-protein recognition by four helix bundles: changing the dimerization specificity of Tet repressor.

Authors:  D Schnappinger; P Schubert; K Pfleiderer; W Hillen
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

8.  An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.

Authors:  P D Aplan; C A Jones; D S Chervinsky; X Zhao; M Ellsworth; C Wu; E A McGuire; K W Gross
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

9.  Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice.

Authors:  Isaac Engel; Cornelis Murre
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

10.  The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells.

Authors:  G G Grütz; K Bucher; I Lavenir; T Larson; R Larson; T H Rabbitts
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.